Mark A. Marzinke

2 ta ish

Johns Hopkins University

1. Transcutaneously refillable nanofluidic implant achieves sustained level of tenofovir diphosphate for HIV pre-exposure prophylaxis

   Corrine Ying Xuan Chua, Priya Jain, Andrea Ballerini +17

   MaqolaOAOchiq kirish20182 iqtibos

   ABIABI:AkademIndex/2026.other.050901

2. 2-Hydroxypropyl-β-cyclodextrin-enhanced pharmacokinetics of cabotegravir from a nanofluidic implant for HIV pre-exposure prophylaxis

   Fernanda P. Pons‐Faudoa, Antons Sizovs, Nicola Di Trani +10

   MaqolaOAOchiq kirish20192 iqtibos

   ABIABI:AkademIndex/2026.other.050907